0001104659-20-028850.txt : 20200303
0001104659-20-028850.hdr.sgml : 20200303
20200303213202
ACCESSION NUMBER: 0001104659-20-028850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sender Gary
CENTRAL INDEX KEY: 0001659085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 20685504
MAIL ADDRESS:
STREET 1: C/O SYNERGY PHARMACEUTICALS INC.
STREET 2: 420 LEXINGTON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2020-02-28
0
0001641640
Nabriva Therapeutics plc
NBRV
0001659085
Sender Gary
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Financial Officer
Ordinary Shares
2020-02-28
4
F
0
301
1.35
D
194281
D
The total reported in Column 5 includes 5,154 shares acquired under Nabriva Therapeutics plc's 2018 Employee Stock Purchase Plan ("ESPP") on April 30, 2019 and 5,759 shares acquired under the ESPP on October 31, 2019.
/s/ Gary Sender
2020-03-03